comparemela.com

Latest Breaking News On - Patients with kras mutated non small cell lung cancer - Page 1 : comparemela.com

Dr Arbour on the Safety and Efficacy of RMC-6236 in KRAS-Mutant NSCLC

Kathryn C. Arbour, MD, discusses preliminary safety and efficacy data with the RAS inhibitor RMC-6236 in patients with KRAS-mutated non–small cell lung cancer.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.